Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2023-11-30 Share Issue/Capital Cha…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Change in number of shares and votes in Elos Medtech
Share Issue/Capital Change Classification · 99% confidence The document explicitly details a change in the number of shares and votes following a rights issue. It quantifies the increase in Series B shares and the resulting total number of shares and votes as of November 30, 2023. This directly relates to changes in the company's capital structure and share count. The most appropriate classification among the provided options is 'Share Issue/Capital Change' (SHA), as it describes the direct outcome of a financing/share issuance activity.
2023-11-30 English
Förändring av antalet aktier och röster i Elos Medtech
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document explicitly details a change in the total number of shares and votes following a rights issue ('företrädesemission'). It provides the 'before' and 'after' counts for Series A and Series B shares and the corresponding total votes, dated November 30, 2023. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general financing update (CAP) but a specific notification of the result of a share issuance.
2023-11-30 Swedish
Elos Medtechs ansökan om avnotering har godkänts
Delisting Announcement Classification · 99% confidence The document text explicitly states that the application for delisting ('ansökan om avnotering') from Nasdaq Stockholm has been approved and specifies the last day of trading ('Sista dag för handel i Elos Medtechs aktier på Nasdaq Stockholm är den 19 december 2023'). This content directly corresponds to the definition of a Delisting Announcement.
2023-11-22 Swedish
Elos Medtech’s application for de-listing has been approved
Delisting Announcement Classification · 100% confidence The document explicitly states that 'Elos Medtech 's application for de-listing has been approved' by Nasdaq Stockholm and specifies the 'last day of trading in Elos Medtech's shares on Nasdaq Stockholm will be 19 December 2023.' This content directly matches the definition for a Delisting Announcement (Code: DLST). The document length is short (1585 chars), but the content is the final announcement of the event, not an announcement about a report, so DLST is preferred over RPA/RNS.
2023-11-22 English
Elos Medtech ansöker om avnotering från Nasdaq Stockholm
Delisting Announcement Classification · 98% confidence The document explicitly states that the Board of Directors of Elos Medtech has decided to apply for the delisting of the Company's shares from Nasdaq Stockholm. This action is a direct consequence of a majority shareholder (controlling over 90%) initiating a compulsory redemption (tvångsinlösen) of the remaining shares. The core subject matter is the official notice of the intent to cease trading on the exchange. This directly matches the definition for 'Delisting Announcement' (Code: DLST). The document length is short (2184 chars), but the content is the announcement itself, not a report about the announcement, so RPA/RNS is less specific than DLST.
2023-11-21 Swedish
Elos Medtech applies for de-listing from Nasdaq Stockholm
Delisting Announcement Classification · 100% confidence The document explicitly states that 'Elos Medtech applies for de-listing from Nasdaq Stockholm'. It details the resolution by the board of directors to apply for de-listing following compulsory redemption initiated by a majority shareholder (controlling over 90%). This content directly corresponds to the definition of a Delisting Announcement (Code: DLST). The document is short and serves as an official notice of this corporate action.
2023-11-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.